Outcomes with Intra-gastric Balloon Therapy in BMI < 35 Non-morbid Obesity: 10-Year Follow-Up Study of an RCT.

Daniel L ChanJosil R CruzWilfred L MuiSimon K H WongEnders Kwok Wai Ng

Published in: Obesity surgery (2020)

IGB delivers weight loss to 2 years and is superior to control. However, new comorbidity development is not significantly different at 10 years. Patient that received IGB therapy were subsequently more willing for further bariatric metabolic intervention.

Keyphrases

weight loss
bariatric surgery
roux en y gastric bypass
gastric bypass
weight gain
randomized controlled trial
metabolic syndrome
body mass index
type diabetes
insulin resistance
obese patients
case report
glycemic control